Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better...
Article - 13 Apr 2004
BioSante Pharmaceuticals, Inc. announced today that the investment firms Merrill Lynch and Punk, Ziegel & Company have included BioSante in their respective indices of nanotechnology companies. Posted...
News - 4 Apr 2013
Novavax, Inc. today announced that top-line data from the Phase II dose-ranging clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age accomplished the...
News - 15 Sep 2009
Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical...
Article - 3 May 2005
The Malvern Zetasizer and zeta potential are invaluable aids in studying the electrokinetics of pulp used in paper manufacture. The Malvern Zetasizer can be used for problem solving by enabling a...
News - 5 Aug 2008
The Zetasizer Nano particle characterization system from Malvern Panalytical has become an essential tool at a water treatment production facility in the US. Here it is being used to monitor the zeta...
Article - 5 Feb 2004
BioSante Pharmaceuticals, Inc. today announced an update on recent developments of its calcium phosphate-based nanotechnology (CAP). Posted February 2 2004
News - 31 Jan 2007
BioSante Pharmaceuticals has announced positive results of a dose ranging pre-clinical study demonstrating that its calcium phosphate (CaP) nanoparticle-based vaccine adjuvant, BioVant(TM), may serve...
News - 2 Jul 2009
DuPont today announced plans with the U.S. Department of Energy (DOE) for a $9 million solar research program --- part of the company's overall effort in providing more mainstream solar...
News - 3 Jul 2020
University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a...